UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 7, 2016
ITUS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 000-11254 | 11-2622630 |
(State or other jurisdiction | (Commission | (IRS Employer Identification No.) |
12100 Wilshire Boulevard, Suite 1275 Los Angeles, CA | 90025 |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (310) 484-5200
(Former name or former address, if changed since last report)
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
ITUS Corporation issued a press release announcing CchekÔ preliminary cancer patient efficacy study results. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed with this Current Report on Form 8-K:
Exhibit No. Description
99.1 Press Release dated December 7, 2016
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 7, 2016 | |||
ITUS CORPORATION | |||
By: | /s/ Robert A. Berman | ||
Name: Robert A. Berman | |||
Title: President and Chief Executive Officer |
3